Dehydroepiandrosterone Supplementation for Poor Responder Patients During in Vitro Fertilization Treatment

Meir Medical Center

Overview

The aim of this study was to evaluate the effect of dehydroepiandrosterone supplementation on in vitro fertilization performance and outcome among poor-responder patient.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Conditions

Ovarian Stimulation

Interventions

dehydroepiandrosterone crystalline fine powderDRUG

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 42 Years

Medical Language ↔ Plain English

Inclusion Criteria: * previous poor response to ovarian stimulation in IVF. Exclusion Criteria: * patients over the age of 42 * patients who received DHEA at any time.

Locations (2)

Meir Medical center IVF unit

Kfar Saba, Kfar Saba, Israel

Meir Medical Center

Kfar Saba, Kfar Sava, Israel

Outcomes

Primary Outcomes

peak estradiol level.

number of retrieved oocytes.

Embryos that were graded as a top quality (according to the number of cells and percent of fragmentation)

number of embryos reserved for transfer.

Secondary Outcomes

pregnancy rate.

live birth rate.

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.